Contents

Search


bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy, Symtuza)

Both Biktarvy & Symtuza contain tenofovir alafenamide Indications: - treatment of HIV1 infection to achieve undetectable HIV1 RNA viral load Dosage: - bictegravir/emtricitabine/tenofovir AF - tablet: 50mg/200mg/25mg - 1 tablet PO QD

General

antiretroviral combination

Database Correlations

PUBCHEM cid=129626368

References

  1. PubChem: 129626368
  2. RxNorm
  3. Medscape: bictegravir/emtricitabine/tenofovir AF (Rx) https://reference.medscape.com/drug/biktarvy-bictegravir-emtricitabine-tenofovir-af-1000199

Components

bictegravir emtricitabine (Emtriva, FTC) tenofovir (TDF)